Literature DB >> 19218503

Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy.

Carlos M Ferrario1, Jasmina Varagic, Javad Habibi, Sayaka Nagata, Johji Kato, Mark C Chappell, Aaron J Trask, Kazuo Kitamura, Adam Whaley-Connell, James R Sowers.   

Abstract

We examined the effects of 48 h bilateral nephrectomy on plasma and cardiac tissue expression of angiotensin-(1-12) [ANG-(1-12)], ANG I, and ANG II in adult Wistar-Kyoto rats to evaluate functional changes induced by removing renal renin. The goal was to expand the evidence of ANG-(1-12) being an alternate renin-independent, angiotensin-forming substrate. Nephrectomy yielded divergent effects on circulating and cardiac angiotensins. Significant decreases in plasma ANG-(1-12), ANG I, and ANG II levels postnephrectomy accompanied increases in cardiac ANG-(1-12), ANG I, and ANG II concentrations compared with controls. Plasma ANG-(1-12) decreased 34% following nephrectomy, which accompanied 78 and 66% decreases in plasma ANG I and ANG II, respectively (P < 0.05 vs. controls). Contrastingly, cardiac ANG-(1-12) in anephric rats averaged 276 +/- 24 fmol/mg compared with 144 +/- 20 fmol/mg in controls (P < 0.005). Cardiac ANG I and ANG II values were 300 +/- 15 and 62 +/- 7 fmol/mg, respectively, in anephric rats compared with 172 +/- 8 fmol/mg for ANG I and 42 +/- 4 fmol/mg for ANG II in controls (P < 0.001). Quantitative immunofluorescence revealed significant increases in average grayscale density for cardiac tissue angiotensinogen, ANG I, ANG II, and AT(1) receptors of WKY rats postnephrectomy. Faint staining of cardiac renin, unchanged by nephrectomy, was associated with an 80% decrease in cardiac renin mRNA. These changes were accompanied by significant increases in p47(phox), Rac1, and Nox4 isoform expression. In conclusion, ANG-(1-12) may be a functional precursor for angiotensin peptide formation in the absence of circulating renin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19218503      PMCID: PMC2670698          DOI: 10.1152/ajpheart.01114.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  43 in total

Review 1.  Clinical pharmacology of ACE inhibition.

Authors:  J Nussberger; B Waeber; H R Brunner
Journal:  Cardiology       Date:  1989       Impact factor: 1.869

2.  Direct formation of angiotensin II without renin or converting enzyme in the ischemic dog heart.

Authors:  M Gondo; H Maruta; K Arakawa
Journal:  Jpn Heart J       Date:  1989-03

3.  Angiotensin II generation in mesenteric arteries in rats: effects of nephrectomy, deoxycorticosterone and dexamethasone.

Authors:  I Miyamori; T Matsubara; Y Takeda; H Koshida; R Soma; R Takeda
Journal:  Endocrinol Jpn       Date:  1990-02

4.  Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy.

Authors:  T Inagami; T Murakami; K Higuchi; S Nakajo
Journal:  Am J Hypertens       Date:  1991-01       Impact factor: 2.689

Review 5.  Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.

Authors:  H Urata; D Ganten
Journal:  Eur Heart J       Date:  1993-11       Impact factor: 29.983

6.  Nephrectomy, converting enzyme inhibition, and angiotensin peptides.

Authors:  D J Campbell; A Kladis; A M Duncan
Journal:  Hypertension       Date:  1993-10       Impact factor: 10.190

7.  Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy.

Authors:  M Nagano; J Higaki; F Nakamura; K Higashimori; N Nagano; H Mikami; T Ogihara
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

8.  Characterization of angiotensin peptides in plasma of anephric man.

Authors:  D J Campbell; A Kladis; S L Skinner; J A Whitworth
Journal:  J Hypertens       Date:  1991-03       Impact factor: 4.844

9.  Immunoreactive adrenomedullin in human plasma.

Authors:  K Kitamura; Y Ichiki; M Tanaka; M Kawamoto; J Emura; S Sakakibara; K Kangawa; H Matsuo; T Eto
Journal:  FEBS Lett       Date:  1994-03-21       Impact factor: 4.124

Review 10.  Tissue renin-angiotensin system: sites of angiotensin formation.

Authors:  D J Campbell
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

View more
  42 in total

Review 1.  The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.

Authors:  Ana Cristina Simões E Silva; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-09-23       Impact factor: 3.714

2.  Cardiovascular responses elicited by a new endogenous angiotensin in the nucleus tractus solitarius of the rat.

Authors:  Vineet C Chitravanshi; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-12       Impact factor: 4.733

3.  Effects of acute kidney dysfunction on hypothalamic arginine vasopressin synthesis in transgenic rats.

Authors:  Hiromichi Ueno; Ryota Serino; Kenya Sanada; Yasuki Akiyama; Kentaro Tanaka; Haruki Nishimura; Kazuaki Nishimura; Satomi Sonoda; Yasuhito Motojima; Reiko Saito; Mitsuhiro Yoshimura; Takashi Maruyama; Tetsu Miyamoto; Masahito Tamura; Yutaka Otsuji; Yoichi Ueta
Journal:  J Physiol Sci       Date:  2019-04-01       Impact factor: 2.781

Review 4.  ACE2: more of Ang-(1-7) or less Ang II?

Authors:  Carlos M Ferrario
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-01       Impact factor: 2.894

Review 5.  New components of the renin-angiotensin system: alamandine and the MAS-related G protein-coupled receptor D.

Authors:  Gisele Maia Etelvino; Antônio Augusto Bastos Peluso; Robson Augusto Souza Santos
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

Review 6.  New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism.

Authors:  Carlos M Ferrario
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

Review 7.  An evolving story of angiotensin-II-forming pathways in rodents and humans.

Authors:  Carlos Maria Ferrario; Sarfaraz Ahmad; Sayaka Nagata; Stephen W Simington; Jasmina Varagic; Neal Kon; Louis Joseph Dell'italia
Journal:  Clin Sci (Lond)       Date:  2014-04       Impact factor: 6.124

8.  Cardiovascular effect of angiotensin-(1-12) in the caudal ventrolateral medullary depressor area of the rat.

Authors:  Tetsuya Kawabe; Kazumi Kawabe; Hreday N Sapru
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

9.  The never-ending story of angiotensin peptides: beyond angiotensin I and II.

Authors:  Louis J Dell'Italia; Carlos M Ferrario
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

Review 10.  Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.

Authors:  Carlos M Ferrario
Journal:  Life Sci       Date:  2009-12-01       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.